Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Renin-angiotensin system blockade is effective in reducing proteinuria of patients with progressive nephropathy caused by MYH9 mutations (Fechtner-Epstein syndrome).

Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association - 1 Aug 2008

Pecci Alessandro, Granata Antonio, Fiore Carmelo E, Balduini Carlo L

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Angiotensin-Converting Enzyme Inhibitors
Share to Angiotensin II Type 1 Receptor Blockers
Share to Benzoates

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Losartan

Share to Molecular Motor Proteins

Share to Proteinuria

Share to Renin-Angiotensin System

Share to Thrombocytopenia

Source

Identifiers

PMID: 18503011
DOI: 10.1093/ndt/gfn277

Genes

MYH9

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Renin-angiotensin system blockade is effective in reducing proteinuria of patients with progressive nephropathy caused by MYH9 mutations (Fechtner-Epstein syndrome).PMID 18503011Read ↗

Management of patients with severe Epstein syndrome: Review of four patients who received living-donor renal transplantation.Semantic proximity Read ↗

CKD in MYH9-related disorders.Semantic proximity Read ↗

Patients with Epstein-Fechtner syndromes owing to MYH9 R702 mutations develop progressive proteinuric renal disease.Semantic proximity Read ↗

Hypertension-associated kidney disease: perhaps no more.Semantic proximity Read ↗

A nationwide survey of MYH9-related disease in Japan.Semantic proximity Read ↗

Polymorphisms in the non-muscle myosin heavy chain 9 gene (MYH9) are strongly associated with end-stage renal disease historically attributed to hypertension in African AmericansSemantic proximity Read ↗

Successful living-related kidney transplantation in MYH9-related disorder with macrothrombocytopenia: lessons for the clinical nephrologist.Semantic proximity Read ↗

Glomerular pathology in autosomal dominant MYH9 spectrum disorders: what are the clues telling us about disease mechanism?Semantic proximity Read ↗

The spectrum of MYH9-associated nephropathy.Semantic proximity Read ↗

[Clinical and genetic basis of hypertensive nephrosclerosis. NEFROSEN Study].Semantic proximity Read ↗

Clinical and molecular characterization of a family with a dominant renin gene mutation and response to treatment with fludrocortisone.Semantic proximity Read ↗

Polymorphisms in the nonmuscle myosin heavy chain 9 gene (MYH9) are associated with albuminuria in hypertensive African Americans: the HyperGEN study.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.